Dogwood Therapeutics, Inc. (DWTX)
1.11
+0.07
(+6.73%)
USD |
NASDAQ |
Nov 06, 10:31
Dogwood Therapeutics EPS Diluted (Quarterly) : -0.3378 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3378 |
| March 31, 2026 | -0.1487 |
| December 31, 2025 | -0.2603 |
| September 30, 2025 | -8.203 |
| June 30, 2025 | -1.992 |
| March 31, 2025 | -8.450 |
| December 31, 2024 | -6.289 |
| September 30, 2024 | -2.054 |
| June 30, 2024 | -1.146 |
| March 31, 2024 | -1.676 |
| December 31, 2023 | -1.432 |
| September 30, 2023 | -1.617 |
| June 30, 2023 | -1.956 |
| March 31, 2023 | -2.069 |
| Date | Value |
|---|---|
| December 31, 2022 | -2.788 |
| September 30, 2022 | -6.999 |
| June 30, 2022 | -11.01 |
| March 31, 2022 | -11.88 |
| December 31, 2021 | -13.54 |
| September 30, 2021 | -12.33 |
| June 30, 2021 | -12.85 |
| March 31, 2021 | -9.176 |
| December 31, 2020 | -19.57 |
| September 30, 2020 | -8.222 |
| June 30, 2020 | -1.976 |
| September 30, 2019 | -2.450 |
| June 30, 2019 | -1.714 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.53M |
| Total Expenses (Quarterly) | 11.53M |
| Enterprise Value | 25.49M |
| Earnings Yield | -806.3% |
| Normalized Earnings Yield | -789.29 |